Everest Medicines Limited (HKG:1952)

Everest Medicines Statistics

Total Valuation

HKG:1952 has a market cap or net worth of HKD 13.50 billion. The enterprise value is 11.49 billion.

Market Cap	13.50B
Enterprise Value	11.49B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1952 has 353.30 million shares outstanding. The number of shares has increased by 4.09% in one year.

Current Share Class	353.30M
Shares Outstanding	353.30M
Shares Change (YoY)	+4.09%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.85%
Owned by Institutions (%)	15.42%
Float	265.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	60.55
PS Ratio	7.11
PB Ratio	2.29
P/TBV Ratio	3.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-34.67
EV / Sales	6.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-65.93

Financial Position

The company has a current ratio of 4.89, with a Debt / Equity ratio of 0.17.

Current Ratio	4.89
Quick Ratio	4.69
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-5.92
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -6.35% and return on invested capital (ROIC) is -7.05%.

Return on Equity (ROE)	-6.35%
Return on Assets (ROA)	-6.51%
Return on Invested Capital (ROIC)	-7.05%
Return on Capital Employed (ROCE)	-9.99%
Weighted Average Cost of Capital (WACC)	13.13%
Revenue Per Employee	2.63M
Profits Per Employee	-458,943
Employee Count	722
Asset Turnover	0.29
Inventory Turnover	22.67

Taxes

Income Tax	-334.51M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.52% in the last 52 weeks. The beta is 1.80, so HKG:1952's price volatility has been higher than the market average.

Beta (5Y)	1.80
52-Week Price Change	-29.52%
50-Day Moving Average	37.77
200-Day Moving Average	51.34
Relative Strength Index (RSI)	54.78
Average Volume (20 Days)	2,997,825

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1952 had revenue of HKD 1.90 billion and -331.36 million in losses. Loss per share was -0.99.

Revenue	1.90B
Gross Profit	1.32B
Operating Income	-683.22M
Pretax Income	-665.87M
Net Income	-331.36M
EBITDA	-532.24M
EBIT	-683.22M
Loss Per Share	-0.99

Balance Sheet

The company has 3.04 billion in cash and 1.03 billion in debt, with a net cash position of 2.01 billion or 5.69 per share.

Cash & Cash Equivalents	3.04B
Total Debt	1.03B
Net Cash	2.01B
Net Cash Per Share	5.69
Equity (Book Value)	5.90B
Book Value Per Share	17.17
Working Capital	2.99B

Cash Flow

In the last 12 months, operating cash flow was -103.00 million and capital expenditures -71.23 million, giving a free cash flow of -174.24 million.

Operating Cash Flow	-103.00M
Capital Expenditures	-71.23M
Depreciation & Amortization	153.74M
Net Borrowing	392.49M
Free Cash Flow	-174.24M
FCF Per Share	-0.49

Margins

Gross margin is 69.25%, with operating and profit margins of -35.97% and -17.45%.

Gross Margin	69.25%
Operating Margin	-35.97%
Pretax Margin	-35.06%
Profit Margin	-17.45%
EBITDA Margin	-28.02%
EBIT Margin	-35.97%
FCF Margin	n/a

Dividends & Yields

HKG:1952 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.09%
Shareholder Yield	-4.09%
Earnings Yield	-2.46%
FCF Yield	-1.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1